AgeForce
English Chinese (Simplified) Chinese (Traditional) Danish Dutch French German Greek Hungarian Irish Italian Japanese Korean Norwegian Polish Portuguese Romanian Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Memory Skin Patch

(Terms & Conditions - Order Options - S&H Fees)

Nootropic Memory Enhancer
View Large Image
Memory Skin Patch

30 Patches -30-Day Supply

Read Customer Reviews

Monthly Autoship - $49.95
Our best price with no long-term obligation

add to cart

3-Month Supply - $179.85 (59.95 each)
You save 2 months S&H

add to cart

6-Month Supply - $299.70 (49.95 each)
You save 5 months S&H

add to cart

1-Month Supply - $69.95

add to cart

Forgetfullstudying for a big examBusiness MeetingTrouble concentratingBrain Power

 

Customer Reviews - We do not monitor or control the content of reviews but reserve the right to remove what are, in our sole opinion, clearly false statements, spam or other injurious materials that are brought to our attention. We do not adopt or endorse any review statement.
Customer ReviewsLeave your reviews
1 of 1 people found the following review helpful
Results With My Mother And Father
I have asked the CS people at AgeForce to post this review for me as my computer is being repaired.
My Mother and Father are both 84 years old and in the last year, I have noted a decline in both of their short-term memory and ability to focus. As I am a real believer in transdermal delivery os prescriptive and non-prescriptive drugs and supplements I thought I would give the AgeForce Nootropic Memory patch a trial for each of them.
Well a year later I can assure anyone that is reading this review that the patch is wonderful! Within 2-months I noted improvement for both of my parents and best of all they did also. Thank You AgeForce for a wonderful patch that has continued to help my parents.
Was this review helpful to you?
2 of 2 people found the following review helpful
Cognitive and Emotional Restoration
This is an excellent product.  I've been struggling with an inability to think clear and stay  "present in the moment" .  I suffered from a series of very traumatic events that caused these and many more debilitating symptoms.  This patch has been a Godsend and a lifesaver for me. It has increased my ability to think and recall incidents and successfully get closure. Please keep making these!!! I never want to be without them,  it feels so good to be a part of life again...
Was this review helpful to you?
0 of 0 people found the following review helpful
A-FIB
I started using the CoQ10 patch and the Nitric Oxide after being diagnosed with A-FIB.  In lest than a week my Heart beat was back to normal.  These patches I would highly recommend for Heart health and Blood Thining.  Looking forward to a long relationship with your patches.
Was this review helpful to you?
3 of 3 people found the following review helpful
Focus after car wreck
I started using this patch after a TBI from a car wreck. Within a week my physical therapist noticed I think quicker and perform tasks easier. Non stim is great for my brain issue but I still feel more focused. Reallt helped a horrible situation get a bit easier!
Was this review helpful to you?
5 of 5 people found the following review helpful
Memory Enhancer patch
I began using this product upon its release this year and have seen sufficient improvement especially in my short term memory. I am 60 years old and was experiencing short term memory loss until using this patch. I'm a customer forever. I highly recommend this product.
Was this review helpful to you?
Leave your reviews
For Questions or Comments


References:

Alekseeva, S. V., et al. "[An experimental study of the anti-inflammatory action of Noopept and its effect on the level of cytokines]." Eksperimental'naia i klinicheskaia farmakologiia 75.9 (2011): 25-27.

Barwell, C. J., et al. "Deamination of hordenine by monoamine oxidase and its action on vasa deferentia of the rat." Journal of pharmacy and pharmacology 41.6 (1989): 421-423. Boiko, S. S., et al. "Bioaccessibility of the new dipeptide nootropic drug Noopept." Pharmaceutical Chemistry Journal 38.12 (2004): 645-647.

Camps, Pelayo, et al. "New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease." Journal of medicinal chemistry 43.24 (2000): 4657-4666.

Fenzl, E., et al. "Long-term study concerning tolerance and efficacy of vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome." Senile Dementias: Early Detection. Szerk.: Bes A. et al.: John Libbey Eurotext (1986): 580-585.

Grandt, R., et al. "Vinpocetine pharmacokinetics in elderly subjects." Arzneimittel-Forschung 39.12 (1989): 1599-1602.

Gudasheva, T. A., et al. "Peptide analogs of piracetam as ligands of presumptive nootrope receptors."Khim.-Farm. Zh. 11 (1985): 1322–1329.

Halliday, R., E. Callaway, and R. Lannon. "The effects of clonidine and Yohimbine on human information processing." Psychopharmacology 99.4 (1989): 563-566.

Jeon, Kye-Im, et al. "Vinpocetine inhibits NF-κB–dependent inflammation via an IKK-dependent but PDE-independent mechanism." Proceedings of the National Academy of Sciences 107.21 (2010): 9795-9800.

Jha, M. K., M. H. Rahman, and Hasib Sheikh. "Vinpocetine: a smart drug and a smart nutrient: a review." IJPSR 3.2 (2012): 346-352.

Jia, Xueen, et al. "Neuroprotective and nootropic drug Noopept rescues α-synuclein amyloid cytotoxicity." Journal of molecular biology 414.5 (2011): 699-712.

Kiss, B., and E. Karpati. "[Mechanism of action of Vinpocetine]." Acta Pharmaceutica Hungarica 66.5 (1996): 213-224.

Kovalenko, L. P., et al. "[Anti-inflammatory properties of Noopept (dipeptide nootropic agent GVS-111)]." Eksperimental'naia i klinicheskaia farmakologiia 65.2 (2001): 53-55.

Lohmann, A., et al. "Bioavailability of vinpocetine and interference of the time of application with food intake." Arzneimittel-Forschung 42.7 (1992): 914-917.

Luo, YiFan, et al. "Solid lipid nanoparticles for enhancing vinpocetine's oral bioavailability." Journal of controlled release 114.1 (2006): 53-59.

Medina, Alexandre E. "Vinpocetine as a potent antiinflammatory agent." Proceedings of the National Academy of Sciences 107.22 (2010): 9921-9922.

Medina, Alexandre E. "Vinpocetine as a potent antiinflammatory agent." Proceedings of the National Academy of Sciences 107.22 (2010): 9921-9922.

Neznamov, G. G., and E. S. Teleshova. "Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin." Neuroscience and behavioral physiology 39.3 (2009): 311-321.

Ostrovskaia, R. U., et al. "[On the mechanism of Noopept action: decrease in activity of stress-induced kinases and increase in expression of neutrophines]." Eksperimental'naia i klinicheskaia farmakologiia 73.12 (2010): 2-5.

Ostrovskaia, R. U., et al. "[The original novel nootropic and neuroprotective agent Noopept]." Eksperimental'naia i klinicheskaia farmakologiia 65.5 (2001): 66-72.

Ostrovskaya, R. U., A. P. Belnik, and Z. I. Storozheva. "Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by β-amyloid25–35 injection into Meynert basal nuclei of rats)." Bulletin of experimental biology and medicine 146.1 (2008b): 77-80.

Ostrovskaya, R. U., A. P. Belnik, and Z. I. Storozheva. "Noopept efficiency in experimental Alzheimer disease (cognitive deficiency caused by β-amyloid₂₅₋ ₃₅ injection into Meynert basal nuclei of rats)." Bulletin of experimental biology and medicine. Bi︠︡ulletenʹ ėksperimentalʹnoĭ biologii i medit︠︡siny (2008c).

Ostrovskaya, R. U., et al. "Efficiency of Noopept in Streptozotocin-Induced Diabetes in Rats." Bulletin of experimental biology and medicine 154.3 (2013): 334-338.

Ostrovskaya, R. U., et al. "Noopept stimulates the expression of NGF and BDNF in rat hippocampus." Bulletin of experimental biology and medicine 146.3 (2008a): 334-337.

Ostrovskaya, Rita U., et al. "The nootropic and neuroprotective proline-containing dipeptide Noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's disease model." Journal of Psychopharmacology 21.6 (2007): 611-619.

Qian, Bo-Chu, et al. "Pharmacokinetics of tablet huperzine A in six volunteers." Zhongguo yao li xue bao= Acta pharmacologica Sinica 16.5 (1995): 396-398.

Romanova, G. A., et al. "Effects of Noopept in the photochemically induced stroke model." Biopolymers. Vol. 71. No. 3. 111 RIVER ST, HOBOKEN, NJ 07030 USA: JOHN WILEY & SONS INC, 2003.

Romanova, G. A., et al. "P. 5.072 Memory restoring and neuroprotective effects of dipeptide Noopept in a photochemical stroke model." European Neuropsychopharmacology 15 (2005): S241.

Smith, Andrew, et al. "Caffeine and central noradrenaline: effects on mood, cognitive performance, eye movements and cardiovascular function." Journal of Psychopharmacology 17.3 (2003): 283-292.

Szakács, Tünde, Zsuzsa Veres, and László Vereczkey. "In vitro-in vivo correlation of the pharmacokinetics of vinpocetine." Polish journal of pharmacology 53.6 (2001): 623-628.

Us, K. S., S. A. Gavrilova, and V. B. Koshelev. "P. 5.066 Neuroprotective properties of the novelnootropic dipeptide Noopept (GVS-111) on the model of severe brain ischemia." European Neuropsychopharmacology 15 (2005): S238.

Vereczkey, L., et al. "Pharmacokinetics of vinpocetine in humans." Arzneimittel-Forschung 29.6 (1978): 957-960.

Xu, S. S., et al. "Huperzine-A in capsules and tablets for treating patients with Alzheimer disease." Zhongguo yao li xue bao= Acta pharmacologica Sinica 20.6 (1999): 486-490.

Zangara, Andrea. "The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease." Pharmacology Biochemistry and Behavior 75.3 (2003): 675-686.

Enter Your Email And Get
40% OFF
Your First Purchase